VBI Vaccines Shares Outstanding 2016-2021 | VBIV

VBI Vaccines shares outstanding from 2016 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
VBI Vaccines Annual Shares Outstanding
(Millions of Shares)
2020 218
2019 119
2018 66
2017 44
2016 30
2015 13
VBI Vaccines Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 255
2021-03-31 251
2020-12-31 218
2020-09-30 235
2020-06-30 217
2020-03-31 178
2019-12-31 119
2019-09-30 106
2019-06-30 98
2019-03-31 97
2018-12-31 66
2018-09-30 64
2018-06-30 64
2018-03-31 64
2017-12-31 44
2017-09-30 40
2017-06-30 40
2017-03-31 40
2016-12-31 30
2016-09-30 36
2016-06-30 28
2016-03-31 19
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.886B $0.001B
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71